Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (https://rgd.mcw.edu/rgdweb/contact/contactus.html).
Term:nervous system disease incidence/prevalence measurement
go back to main search page
Accession:CMO:0002362 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display any disease, lesion or abnormality of the nervous system at a point in time or develop a disease, lesion or abnormality of the nervous system within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio.
Synonyms:xref: MESH:D009422


show annotations for term's descendants           Sort by:
encephalitis incidence/prevalence measurement term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Vie1 Viral induced encephalitis QTL 1 IDA 26.4 RGD PMID:22761571 RGD:7240516 NCBI chr 4:1...35,396,961 JBrowse link
Q Vie2 Viral induced encephalitis QTL 2 IDA 4.1 RGD PMID:22761571 RGD:7240516 NCBI chr 3:166,376,089...189,428,310 JBrowse link
Q Vie3 Viral induced encephalitis QTL 3 IDA 2.6 RGD PMID:22761571 RGD:7240516
Q Vie4 Viral induced encephalitis QTL 4 IDA 7.3 RGD PMID:22761571 RGD:7240516 NCBI chr 4:18,900,697...63,900,697 JBrowse link
Q Vie5 Viral induced encephalitis QTL 5 IDA 25.3 RGD PMID:22761571 RGD:7240516 NCBI chr 4:1...35,396,961 JBrowse link
experimental autoimmune encephalomyelitis incidence/prevalence measurement term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Eae12 Experimental allergic encephalomyelitis QTL 12 IDA 9.0E-4 RGD PMID:10545597 RGD:69695 NCBI chr10:73,599,825...107,713,808 JBrowse link
Q Eae13 Experimental allergic encephalomyelitis QTL 13 IDA 0.032 RGD PMID:10545597 RGD:69695 NCBI chr12:29,775,522...42,298,555 JBrowse link
Q Eae14 Experimental allergic encephalomyelitis QTL 14 IDA 0.0024 RGD PMID:10545597 RGD:69695
Q Eae15 Experimental allergic encephalomyelitis QTL 15 IDA 0.001 RGD PMID:10545597 RGD:69695 NCBI chr18:79,484,311...84,129,249 JBrowse link
Q Eae16 Experimental allergic encephalomyelitis QTL 16 IDA 3.8 RGD PMID:12517974 RGD:629629 NCBI chr 8:68,690,349...119,799,881 JBrowse link
Q Eae17 Experimental allergic encephalomyelitis QTL 17 IDA 4.1 RGD PMID:12517974 RGD:629629 NCBI chr13:1...8,904,467 JBrowse link
Q Eae2 Experimental allergic encephalomyelitis QTL 2 IDA 4.3 RGD PMID:9973459 RGD:69694 NCBI chr 4:22,288,453...40,471,598 JBrowse link
Q Eae3 Experimental allergic encephalomyelitis QTL 3 IDA 4.1 RGD PMID:9973459 RGD:69694 NCBI chr10:27,023,535...61,843,633 JBrowse link
Q Eae4 Experimental allergic encephalomyelitis QTL 4 IDA RGD PMID:10072499 RGD:69712 NCBI chr 9:5,474,096...6,714,888 JBrowse link
percentage of study population developing cerebrovascular lesions during a period of time term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Strs4 Sensitivity to stroke QTL 4 IDA 8.7 RGD PMID:23690346 RGD:7411685 NCBI chr 1:87,558,587...132,558,587 JBrowse link
Q Strs5 Sensitivity to stroke QTL 5 IDA 9.4 RGD PMID:23690346 RGD:7411685 NCBI chr18:52,198,059...68,120,379 JBrowse link
Q Strs6 Sensitivity to stroke QTL 6 IDA 3.9 RGD PMID:23690346 RGD:7411685 NCBI chr 5:140,258,140...143,398,122 JBrowse link
Q Strs7 Sensitivity to stroke QTL 7 IDA 3.8 RGD PMID:23690346 RGD:7411685 NCBI chr15:44,465,447...56,583,797 JBrowse link
percentage of study population developing experimental autoimmune encephalomyelitis during a period of time term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Eae20 Experimental allergic encephalomyelitis QTL 20 IDA 7.8 RGD PMID:15634914 RGD:1547849
Q Eae24 Experimental allergic encephalomyelitis QTL 24 IDA RGD PMID:19675581 RGD:2317591 NCBI chr 4:67,960,112...73,752,811 JBrowse link
Q Eae25 Experimental allergic encephalomyelitis QTL 25 IDA 9.300000190734863 RGD PMID:19675581 RGD:2317591 NCBI chr 4:80,213,634...84,338,055 JBrowse link
Q Eae27 Experimental allergic encephalomyelitis QTL 27 IDA RGD PMID:19675581 RGD:2317591 NCBI chr 4:69,036,742...114,036,742 JBrowse link
Q Eae8 Experimental allergic encephalomyelitis QTL 8 IDA 4.0 RGD PMID:10640775 RGD:61031 NCBI chr19:41,720,609...49,971,820 JBrowse link
percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Eae10 Experimental allergic encephalomyelitis QTL 10 IDA 3.5 RGD PMID:10640775 RGD:61031 NCBI chr14:17,906,850...18,558,619 JBrowse link
Q Eae5 Experimental allergic encephalomyelitis QTL 5 IDA 14.0 RGD PMID:10640775 RGD:61031
Term paths to the root